Drug Profile
Research programme: breast cancer vaccine - CEL-SCI/Northeast Ohio Medical University
Alternative Names: J-HER vaccine - CEL-SCI/Northeast Ohio Medical University; J-HER vaccine - CEL-SCI/Northeastern Ohio Universities College of MedicineLatest Information Update: 23 Mar 2023
Price :
$50
*
At a glance
- Originator CEL-SCI Corporation; Northeast Ohio Medical University
- Developer CEL-SCI Corporation
- Class Cancer vaccines
- Mechanism of Action Apoptosis stimulants; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer
Most Recent Events
- 23 Mar 2023 Breast cancer vaccine is still in preclinical trials for Breast cancer in USA
- 28 Jul 2018 No recent reports of development identified for preclinical development in Breast-cancer in USA (Parenteral)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Breast-cancer(Prevention) in USA (Parenteral)